{
    "title": "Seattle Genetics, Astellas drug rapidly shrinks tumors in bladder cancer study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7099755/Seattle-Genetics-Astellas-drug-rapidly-shrinks-tumors-bladder-cancer-study.html",
    "date": "2019-06-03",
    "keywords": [
        "cancer",
        "bladder",
        "response",
        "treatment",
        "drug",
        "tumor",
        "trial",
        "chemotherapy",
        "tamara",
        "inc",
        "shrinkage",
        "study",
        "enfortumab",
        "prognosis",
        "liver",
        "dr",
        "petrylak",
        "center",
        "data",
        "society",
        "oncology",
        "asco",
        "meeting",
        "chicago",
        "approval",
        "year",
        "immunotherapy",
        "midstage",
        "rate",
        "meaning",
        "merck",
        "amp",
        "cos",
        "keytruda",
        "course",
        "yale",
        "statement",
        "vedotin",
        "type",
        "antibodydrug",
        "conjugate",
        "antibody",
        "protein",
        "surface",
        "payload",
        "bomb",
        "share",
        "development",
        "population",
        "robert",
        "dreicer",
        "oncologist",
        "university",
        "virginia",
        "expert",
        "addition",
        "goal",
        "cycle",
        "duration",
        "benefit",
        "survival",
        "latestage",
        "priority",
        "hardtotreat",
        "head",
        "phone",
        "interview",
        "reporting",
        "bengaluru",
        "julie",
        "steenhuysen",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}